BANK VONTOBEL/CALL/NOVARTIS N/88/0.1/20.09.24 Share Price

Warrant

WNOAGV

CH1290653992

Market Closed - Bid/Ask 08:50:00 20/06/2024 pm IST After market 08:45:00 pm
0.75 CHF +1.35% Intraday chart for BANK VONTOBEL/CALL/NOVARTIS N/88/0.1/20.09.24 0.745 -0.67%
Current month+11.94%
1 month+5.63%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
20/24/20 0.75 +1.35%
19/24/19 0.74 +8.82%
18/24/18 0.68 -6.85%
17/24/17 0.73 -13.10%
14/24/14 0.84 +6.33%

Delayed Quote Swiss Exchange

Last update June 20, 2024 at 08:50 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying NOVARTIS AG
IssuerLogo Issuer Vontobel Vontobel
WNOAGV
ISINCH1290653992
Date issued 05/10/2023
Strike 88 CHF
Maturity 20/09/2024 (91 Days)
Parity 10 : 1
Emission price 0.52 CHF
Emission volume N/A
Settlement physical
Currency CHF

Technical Indicators

Highest since issue 0.85 CHF
Lowest since issue 0.182 CHF
Spread 0.01 CHF
Spread %1.33%

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
105.9 USD
Average target price
110.3 USD
Spread / Average Target
+4.16%
Consensus
  1. Stock Market
  2. Warrants
  3. WNOAGV Warrant